Literature DB >> 19938750

Extrapontine myelinolysis in preoperative sellar region tumor: report of two cases.

Duangpol Srimanee1, Roongroj Bhidayasiri, Kammant Phanthumchinda.   

Abstract

Osmotic demyelination syndrome (ODS) is a well-known disorder caused by rapid correction of serum sodium. Many conditions including hormonal abnormality are associated with this syndrome. The authors describe two cases of preoperative sellar region tumor associated with hypopituitarism and secondary adrenal insufficiency. These two patients had hyponatremia. Neurological manifestations in both of them were generalized dystonia. Magnetic resonance imaging (MRI) revealed a characteristic extrapontine myelinolysis (EPM). The first case was a 35-year-old man with craniopharyngioma who developed generalized dystonia after rapid correction of hyponatremia. The second case was a 24-year-old man with gonadotroph pituitary adenoma who developed generalized dystonia, dysarthria, and dysphagia in the course of hyponatremia. Hormonal changes will cause fluctuation in hyponatremia and correction of hyponatremia, even if the recommended rate may be hazardous and will promote ODS. Patients with sellar region tumors are at risk of developing ODS and correction of hyponatremia in these cases should be closely monitored.

Entities:  

Mesh:

Year:  2009        PMID: 19938750

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  3 in total

1.  Preoperative Extrapontine Myelinolysis with Good Outcome in a Patient with Pituitary Adenoma.

Authors:  Ying Zhou; Yicheng Zhu; Wenze Wang; Bing Xing
Journal:  J Korean Neurosurg Soc       Date:  2016-02-29

2.  Extrapontine myelinolysis of osmotic demyelination syndrome in a case of postoperative suprasellar arachnoid cyst.

Authors:  Peng Zhao; Xuyi Zong; Xinsheng Wang; Yazhuo Zhang
Journal:  Case Rep Med       Date:  2012-12-27

3.  Extrapontine myelinolysis-induced parkinsonism in a patient with adrenal crisis.

Authors:  Yahia Z Imam; Maher Saqqur; Hassan Alhail; Dirk Deleu
Journal:  Case Rep Neurol Med       Date:  2012-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.